- Works count
- 1,171
- Citation count
- 42,713
- H-index
- 88
- i10-index
- 406
Research interests
Publications
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
American Journal of Respiratory and Critical Care Medicine · 2023 · https://doi.org/10.1164/rccm.202301-0106pp
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
European Respiratory Journal · 2023 · https://doi.org/10.1183/13993003.00239-2023
Air pollution and COPD: GOLD 2023 committee report
European Respiratory Journal · 2023 · https://doi.org/10.1183/13993003.02469-2022
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
European Heart Journal · 2022 · https://doi.org/10.1093/eurheartj/ehac237
Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline
European Respiratory Journal · 2021 · https://doi.org/10.1183/13993003.00048-2021
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Science · 2020 · https://doi.org/10.1126/science.abc6027
Impaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patients
medRxiv · 2020 · https://doi.org/10.1101/2020.04.19.20068015
From GOLD 0 to Pre-COPD
American Journal of Respiratory and Critical Care Medicine · 2020 · 10.1164/rccm.202008-3328pp
Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data
BMJ · 2020 · https://doi.org/10.1136/bmj.m1844
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019
European Respiratory Journal · 2019 · https://doi.org/10.1183/13993003.00164-2019
Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial
The Lancet Respiratory Medicine · 2019 · 10.1016/s2213-2600(19)30190-0
Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence
Journal of Allergy and Clinical Immunology · 2019 · https://doi.org/10.1016/j.jaci.2019.06.049
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial
The Lancet · 2018 · 10.1016/s0140-6736(18)30206-x
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
European Respiratory Journal · 2017 · https://doi.org/10.1183/13993003.00214-2017
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary
American Journal of Respiratory and Critical Care Medicine · 2017 · https://doi.org/10.1164/rccm.201701-0218pp
European Respiratory Society statement: diagnosis and treatment of pulmonary disease in α 1 -antitrypsin deficiency
European Respiratory Journal · 2017 · https://doi.org/10.1183/13993003.00610-2017
Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report
Respirology · 2017 · 10.1111/resp.13012
Informe 2017 de la Iniciativa Global para el Diagnóstico, Tratamiento y Prevención de la Enfermedad Pulmonar Obstructiva Crónica: Resumen Ejecutivo de GOLD
Archivos de Bronconeumología · 2017 · 10.1016/j.arbres.2017.02.001
Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD
New England Journal of Medicine · 2016 · 10.1056/nejmoa1516385
A review of national guidelines for management of COPD in Europe
European Respiratory Journal · 2016 · https://doi.org/10.1183/13993003.01170-2015
Epidemiology of spontaneous pneumothorax: gender-related differences
Thorax · 2015 · 10.1136/thoraxjnl-2014-206577
Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management
The Lancet · 2015 · 10.1016/s0140-6736(15)60693-6
Current evidence and future research needs for FeNO measurement in respiratory diseases
Respiratory Medicine · 2014 · https://doi.org/10.1016/j.rmed.2014.02.005
Observational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS study
Respiratory Research · 2014 · https://doi.org/10.1186/s12931-014-0122-1
Choosing inhaler devices for people with asthma: Current knowledge and outstanding research needs
Respiratory Medicine · 2010 · https://doi.org/10.1016/j.rmed.2010.04.012
Clinical COPD phenotypes: a novel approach using principal component and cluster analyses
European Respiratory Journal · 2010 · 10.1183/09031936.00175109
Cough and Sputum Production Are Associated With Frequent Exacerbations and Hospitalizations in COPD Subjects
CHEST Journal · 2008 · 10.1378/chest.08-2062
Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability
European Respiratory Journal · 2002 · 10.1183/09031936.02.00218402
Balance of Matrix Metalloprotease-9 and Tissue Inhibitor of Metalloprotease-1 from Alveolar Macrophages in Cigarette Smokers
American Journal of Respiratory and Critical Care Medicine · 2000 · 10.1164/ajrccm.162.4.9910097
Current projects
No projects listed.